Abvc Biopharma annual gross margin
2015
2018
2019
2020
2021
2022
2023
Abvc Biopharma Gross Margin Growth & History (ABVC)
Abvc Biopharma's gross margin was −98.15% for fiscal 2023.
View full Abvc Biopharma company overviewAbvc Biopharma annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −98.15% | −168.61 pp |
| 2022 | 2022-12-31 | 70.47% | −28.10 pp |
| 2021 | 2021-12-31 | 98.57% | +2.45 pp |
| 2020 | 2020-12-31 | 96.13% | −1.00 pp |
| 2019 | 2019-12-31 | 97.13% | +2660.73 pp |
| 2018 | 2018-12-31 | −2,563.60% | −2648.09 pp |
| 2015 | 2015-09-30 | 84.49% | — |
Abvc Biopharma quarterly gross margin
Q2.15
Q1.17
Q3.17
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q3.25
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-09-30 | 100.00% | +6429.84 pp |
| Q3 2024 | 2024-09-30 | 99.92% | +186.36 pp |
| Q2 2024 | 2024-06-30 | 99.84% | +1194.49 pp |
| Q1 2024 | 2024-03-31 | 77.01% | +23.97 pp |
| Q4 2023 | 2023-12-31 | −6,329.84% | −6384.78 pp |
| Q3 2023 | 2023-09-30 | −86.44% | −161.03 pp |
| Q2 2023 | 2023-06-30 | −1,094.65% | −1191.97 pp |
| Q1 2023 | 2023-03-31 | 53.04% | −39.57 pp |
| Q4 2022 | 2022-12-31 | 54.94% | −44.66 pp |
| Q3 2022 | 2022-09-30 | 74.59% | −23.36 pp |
| Q2 2022 | 2022-06-30 | 97.33% | −2.20 pp |
| Q1 2022 | 2022-03-31 | 92.61% | −4.33 pp |
| Q3 2021 | 2021-09-30 | 99.60% | +7.06 pp |
| Q2 2021 | 2021-06-30 | 97.95% | −0.18 pp |
| Q1 2021 | 2021-03-31 | 99.53% | +4.55 pp |
| Q4 2020 | 2020-12-31 | 96.94% | −0.57 pp |
| Q3 2020 | 2020-09-30 | 92.54% | −6.04 pp |
| Q2 2020 | 2020-06-30 | 98.13% | +5.09 pp |
| Q1 2020 | 2020-03-31 | 94.97% | −4.32 pp |
| Q4 2019 | 2019-12-31 | 97.51% | +69.40 pp |
| Q3 2019 | 2019-09-30 | 98.59% | +70.40 pp |
| Q2 2019 | 2019-06-30 | 93.04% | −6.96 pp |
| Q1 2019 | 2019-03-31 | 99.29% | −0.71 pp |
| Q3 2018 | 2018-09-30 | 28.11% | −58.57 pp |
| Q2 2018 | 2018-06-30 | 28.18% | — |
| Q3 2017 | 2017-06-30 | 100.00% | — |
| Q1 2017 | 2016-12-31 | 100.00% | — |
| Q2 2015 | 2015-03-31 | 86.68% | — |
Abvc Biopharma gross margin trends
Over the last five reported fiscal years, Abvc Biopharma's gross margin increased from −2,563.60% to −98.15%, a change of +2465.45 percentage points. The latest reported quarter, Q3 2025, shows 100.00%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abvc Biopharma filings at SEC.gov ↗